Chemoinformaics analysis of 4,7,7-Trimethylbicyclo[3.2.0]hept-3-en-6-one
| Molecular Weight | 150.221 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 9 |
| Exact Molecular Weight | 150.104 | nRing | 2 |
| Solubility: LogS | -3.166 | nHRing | 0 |
| Solubility: LogP | 2.786 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 26.8371 |
| nHD | 0 | BPOL | 14.9129 |
| QED | 0.518 |
| Synth | 3.66 |
| Natural Product Likeliness | 1.873 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.418 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.55 |
| MDCK | 0.0000293 |
| BBB | 0.227 |
| PPB | 0.884169 |
| VDSS | 0.979 |
| FU | 0.19093 |
| CYP1A2-inh | 0.572 |
| CYP1A2-sub | 0.796 |
| CYP2c19-inh | 0.557 |
| CYP2c19-sub | 0.888 |
| CYP2c9-inh | 0.123 |
| CYP2c9-sub | 0.5 |
| CYP2d6-inh | 0.11 |
| CYP2d6-sub | 0.484 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.479 |
| CL | 4.694 |
| T12 | 0.179 |
| hERG | 0.016 |
| Ames | 0.01 |
| ROA | 0.053 |
| SkinSen | 0.219 |
| Carcinogencity | 0.177 |
| EI | 0.542 |
| Respiratory | 0.956 |
| NR-Aromatase | 0.08 |
| Antiviral | No |
| Prediction | 0.929157 |